Issuu on Google+


Araujo M. et al., Int. J. Periodontics Restorative Dent. 2008; 28:123–135.


Araujo M. et al., Clinical oral implants research 2009; 20:433–440.


Jung RE et al. J Clin Periodontol. 2013 Jan, 40(1):90–8.


Geistlich Mucograft® Seal report on the meeting of the Advisory Committee, 2013, data on file.


Thoma D. et al., J. Clin. Periodontol 2012; 39:157–165.


Hämmerle C. et al., ITI Consensus statement FDDH; EM:supplementation.

Visit us at

Subsidiary Great Britain, Ireland Geistlich Sons Limited 1st Floor, Thorley House Bailey Lane Manchester Airport GB Manchester M90 4AB Phone +44 1 614 902 038 Fax +44 1 614 986 988

ADX in Sydney Glebe Island 21-23 March

Manufacturer: Geistlich Pharma AG Business Unit Biomaterials Bahnhofstrasse 40 CH-6110 Wolhusen Tel. +41-41-4925 555 Fax +41-41-4925 639

More details about our distribution partners: ® The new Geistlich Mucograft Seal collagen matrix is essential for this minimally invasive approach. Developed especially for ridge preservation, it can be used for extraction sockets with intact buccal bone lamella.

Benefit from the advantages Ridge preservation minimises volume loss of the alveolar bone after tooth extraction and the need for subsequent bone augmentation is reduced 10-fold1,2. In addition, closing the alveolus with Geistlich Mucograft® Seal optimally regenerates soft tissue2. More flexibility for subsequent procedures – an implant can be placed after only 8 to 10 weeks3. Furthermore, bone and soft tissue are also optimally prepared for future implant placement or bridge reconstruction.

Watch the expert Swiss expert PD Dr. Ronald E. Jung demonstrates a ridge preservation in an alveolus with intact buccal bone wall.


References: 1. 2. 3.

Jung RE, et al. : J Clin Periodontol 2013; 40(1): 90-98. Weng D, et al.: Eur J Oral Implantol 2011; 4 Suppl: 59-66. Geistlich Mucograft Seal Advisory Board Meeting Report, 2013. Date on file, Geistlich Pharma AG, Wolhusen, Switzerland.

Watch the Expert